Xilio Therapeutics (XLO) Share-based Compensation (2020 - 2026)
Xilio Therapeutics (XLO) recorded Share-based Compensation of $1.6 million in Q2 2026, up 18.3% from $1.35 million a year earlier but down 27.7% from the prior quarter.
Powered by 
Analysis
Xilio Therapeutics (XLO) Share-based Compensation (2020 - 2026) Analysis & Trends
On a TTM basis, Xilio Therapeutics' Share-based Compensation came in at $7.86 million as of Jun 30, 2026, up 31.6% year-over-year; for FY2025, it was $6.94 million, up 7.8% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 39.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $6.43 million in FY2024 (-12.8%), $7.38 million in FY2023 (-12.4%), $8.42 million in FY2022 (+69.9%) and $4.96 million in FY2021 (+282.6%).
- Quarterly Share-based Compensation has ranged from $1.09 million in Q3 2021 to $2.93 million in Q4 2025 over the past five years.
- On a year-over-year basis, Share-based Compensation has increased for three consecutive quarters, with growth averaging 7.9% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 465.8% in Q4 2021, against a decline of 33.6% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.21 million (Q1 2026), $2.93 million (Q4 2025) and $1.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Xilio Therapeutics | 157.76 Mn | -369.91 Mn | - | 1.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Mar 31, 2026 | 2.21 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 2.71 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | 1.09 Mn |
API Access
Xilio Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();